England
| Name | Miles | Days Ridden | Trips |
|---|---|---|---|
| Emma Koppe | 248 | 7 | 8 |
| Simon Knee | 193 | 9 | 9 |
| Nick Barton | 190 | 5 | 5 |
| Cassie Pratley | 186 | 15 | 27 |
| Matt Kirk | 110 | 30 | 48 |
| Name | Riders in challenge | Participation | Trips |
|---|---|---|---|
| BPR | 1 | 33% | 2 |
| Biopharm R&D | 1 | 33% | 5 |
| BIB | 1 | 8% | 2 |
| SFC (UK) | 2 | 4% | 16 |
| Product Development | 1 | 2% | 27 |
| Epinova | 1 | 1% | 3 |
| Name | Department | Last login | ||
|---|---|---|---|---|
| Benjamin Griffith | SFC (UK) | over 1 year | Message | |
| Steve Thomas | SFC (UK) | over 1 year | Message | |
| Olufunke Akiyode | SFC (UK) | over 2 years | Message | |
| Sean Lynn | SFC (UK) | over 2 years | Message | |
| Petra Booij | SFC (UK) | over 2 years | Message | |
| Alistair Greenlaw | Product Development | over 2 years | Message | |
| Victoria Lando | over 2 years | Message | ||
| Guilherme De Castro | Medicine Design | over 2 years | Message | |
| David King | over 3 years | Message | ||
| Sam Payne | over 3 years | Message |
| Name | staff | Riders | Distance (miles) | Trips | Transport Trips |
|---|---|---|---|---|---|
| CMC Analytical | 100 | 0 | 0 | 0 | 0 |
| PSDE | 50 | 1 | 104 | 32 | 0 |
| PTS-DDS | 250 | 1 | 186 | 19 | 10 |
| AS | 100 | 1 | 69 | 3 | 2 |
| CSci | 400 | 0 | 0 | 0 | 0 |
| BPR | 3 | 3 | 6711 | 368 | 99 |
| GAC | 50 | 2 | 1188 | 44 | 5 |
| Biopharm Innovation | 50 | 1 | 4 | 1 | 1 |
| Respiratory | 30 | 6 | 8662 | 686 | 318 |
| Respiratory | 30 | 3 | 2699 | 221 | 66 |
| DMS | 12 | 0 | 0 | 0 | 0 |
| R&D S&P | 12 | 2 | 20 | 7 | 5 |
| ATD | 40 | 3 | 76 | 8 | 8 |
| AIML | 15 | 0 | 0 | 0 | 0 |
| Emcor Engineering | 120 | 0 | 0 | 0 | 0 |
| SM Tech | 50 | 0 | 0 | 0 | 0 |
| CGT | 400 | 6 | 8003 | 873 | 412 |
| AIRU | 120 | 3 | 1695 | 109 | 93 |
| Bioimaging | 30 | 2 | 1038 | 114 | 34 |
| QPPV Office | 8 | 0 | 0 | 0 | 0 |
| CDQA | 30 | 0 | 0 | 0 | 0 |
| Epinova | 100 | 2 | 1193 | 349 | 147 |
| GDS | 3 | 0 | 0 | 0 | 0 |
| LAS | 60 | 0 | 0 | 0 | 0 |
| Product Development | 50 | 4 | 17795 | 662 | 214 |
| TSci | 200 | 1 | 6 | 1 | 1 |
| CPEM Biomarkers | 9 | 1 | 130 | 25 | 0 |
| SFC (UK) | 48 | 7 | 18801 | 1503 | 449 |
| Biopharm R&D | 3 | 2 | 7589 | 341 | 49 |
| ComputationalBiology | 40 | 1 | 1066 | 66 | 1 |
| RMA | 15 | 0 | 0 | 0 | 0 |
| BSci | 80 | 0 | 0 | 0 | 0 |
| SEMA QA | 3 | 0 | 0 | 0 | 0 |
| Data & Computational Science | 400 | 5 | 4732 | 281 | 17 |
| Drug Substance and Product Analysis | 100 | 1 | 1813 | 95 | 49 |
| CPEM Discovery Medicine | 15 | 2 | 33 | 7 | 1 |
| IVSD | 20 | 1 | 5 | 2 | 2 |
| BIB | 12 | 1 | 5017 | 348 | 39 |
| Medicine Design | 600 | 6 | 22937 | 1618 | 1029 |
| WREF | 200 | 3 | 12990 | 2838 | 2291 |
| Strategy Portfolio & Operations | 3 | 0 | 0 | 0 | 0 |
| Discovery DMPK | 25 | 1 | 163 | 40 | 40 |
| C3 | 20 | 1 | 8 | 4 | 4 |
| SPMB | 60 | 1 | 1328 | 51 | 8 |
| GSK Tech | 50 | 2 | 1443 | 102 | 15 |
| Tech Stewards | 8 | 1 | 6 | 1 | 1 |
| Biostatistics | 100 | 1 | 1 | 1 | 0 |
| IBPS | 3 | 1 | 20 | 1 | 0 |
| This can be deleted. | 1 | 0 | 0 | 0 | 0 |
